Inhibition of angiopoietin-2 with L1-10 peptibody reduced angiogenesis, ameliorated steatohepatitis and prevented NASH-associated HCC progression in mice (Lefere et al., 2019). The gene discussed is ANGPT2; the disease is metabolic dysfunction-associated steatohepatitis.